Kitchener, Ontario nanotechnology startup Nicoya Lifesciences Inc has secured $2 million in its latest financing. U.S. venture capital firm Ripple Ventures and Canadian angel group Golden Triangle Angel Network (GTAN) led the round. They were joined by MaRS Investment Accelerator Fund, BDC Capital, Garage Capital, Angel One, Maple Leaf Angels, Innovation Grade Ventures and others. Launched in 2012, Nicoya’s premiere product is OpenSPR, a biosensor platform that supports R&D applications in a range of fields, from pharmaceuticals to diagnostics. The funds raised will be used for new product development and sales and marketing.